| CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry S Purkait, P Jha, MC Sharma, V Suri, M Sharma, SS Kale, C Sarkar Neuropathology 33 (4), 405-412, 2013 | 64 | 2013 |
| Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM P Pathak, P Jha, S Purkait, V Sharma, V Suri, MC Sharma, M Faruq, ... Journal of neuro-oncology 121, 489-497, 2015 | 62 | 2015 |
| Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults P Jha, V Suri, G Singh, P Jha, S Purkait, P Pathak, V Sharma, MC Sharma, ... Diagnostic Molecular Pathology 20 (4), 225-232, 2011 | 54 | 2011 |
| Genome‐wide small noncoding RNA profiling of pediatric high‐grade gliomas reveals deregulation of several mi RNA s, identifies downregulation of sno RNA cluster HBII‐52 and … P Jha, R Agrawal, P Pathak, A Kumar, S Purkait, S Mallik, V Suri, ... International journal of cancer 137 (10), 2343-2353, 2015 | 48 | 2015 |
| A study of clinico‐pathological parameters and O6 – methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of … G Singh, S Mallick, V Sharma, N Joshi, S Purkait, P Jha, MC Sharma, ... Neuropathology 32 (5), 534-542, 2012 | 35 | 2012 |
| Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low-and high-grade astrocytic tumors V Sharma, PB Malgulwar, S Purkait, V Patil, P Pathak, R Agrawal, ... Carcinogenesis 38 (2), 152-161, 2017 | 34 | 2017 |
| Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas A Kumar, P Pathak, S Purkait, M Faruq, P Jha, S Mallick, V Suri, ... Cancer genetics 208 (3), 91-95, 2015 | 32 | 2015 |
| The Milan System for Reporting Salivary Gland Cytopathology: assessment of cytohistological concordance and risk of malignancy S Jha, S Mitra, S Purkait, AK Adhya Acta Cytologica 65 (1), 27-39, 2021 | 30 | 2021 |
| Genetic alterations related to BRAF‐FGFR genes and dysregulated MAPK/ERK/m TOR signaling in adult pilocytic astrocytoma P Pathak, A Kumar, P Jha, S Purkait, M Faruq, A Suri, V Suri, MC Sharma, ... Brain pathology 27 (5), 580-589, 2017 | 29 | 2017 |
| EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB‐1 proliferation index S Purkait, V Sharma, P Jha, MC Sharma, V Suri, A Suri, BS Sharma, ... Neuropathology 35 (5), 421-431, 2015 | 28 | 2015 |
| Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma S Purkait, S Agarwal, SR Mathur, D Jain, VK Iyer Cytopathology 27 (3), 176-184, 2016 | 27 | 2016 |
| Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas S Purkait, V Sharma, A Kumar, P Pathak, S Mallick, P Jha, MC Sharma, ... Experimental and molecular pathology 100 (2), 312-320, 2016 | 27 | 2016 |
| ATRX in diffuse gliomas with its mosaic/heterogeneous expression in a subset S Purkait, CA Miller, A Kumar, V Sharma, P Pathak, P Jha, MC Sharma, ... Brain Pathology 27 (2), 138-145, 2017 | 25 | 2017 |
| Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas K Kaur, A Kakkar, A Kumar, S Purkait, S Mallick, V Suri, MC Sharma, ... Journal of neuro-oncology 130, 423-430, 2016 | 23 | 2016 |
| Clinicopathological and molecular characteristics of pediatric meningiomas S Battu, A Kumar, P Pathak, S Purkait, L Dhawan, MC Sharma, A Suri, ... Neuropathology 38 (1), 22-33, 2018 | 21 | 2018 |
| Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas A Kumar, S Nayak, P Pathak, S Purkait, PB Malgulawar, MC Sharma, ... Journal of Neuro-oncology 139, 23-31, 2018 | 19 | 2018 |
| Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors V Sharma, S Purkait, S Takkar, PB Malgulwar, A Kumar, P Pathak, V Suri, ... Brain tumor pathology 33, 117-128, 2016 | 18 | 2016 |
| Prognostic stratification of GBMs using combinatorial assessment of IDH1 mutation, MGMT promoter methylation, and TERT mutation status: experience from a tertiary care center … S Purkait, S Mallick, V Sharma, A Kumar, P Pathak, P Jha, A Biswas, ... Translational Oncology 9 (4), 371-376, 2016 | 16 | 2016 |
| Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas–prognostic biomarkers for routine practice S Samal, A Patnaik, F Sahu, S Purkait Folia Neuropathologica 58 (2), 133-142, 2020 | 15 | 2020 |
| Retroperitoneal and mediastinal follicular dendritic cell sarcoma: report of 3 cases with review of literature S Purkait, S Mallick, PP Joshi, S Mallick, NV Murugan, MC Sharma, V Suri, ... Hematological Oncology 35 (3), 374-379, 2017 | 14 | 2017 |
